Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

663
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
663
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

851
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
851
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

953
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
953

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reactive oxygen species alter dopaminergic and purinergic signaling and microglia physiology in the nucleus accumbens.

bioRxiv : the preprint server for biology·2026
Same author

Shared mechanisms of dopamine and ATP transmission in the nucleus accumbens.

bioRxiv : the preprint server for biology·2026
Same author

Bile Acids Regulate Accumbal Cholinergic Circuitry and Dopamine Release through TGR5 Activation.

bioRxiv : the preprint server for biology·2026
Same author

Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson Disease.

The American journal of pathology·2026
Same author

Monocyte-Derived Macrophages Expressing Dopamine D2-Subtype Receptors Drive Alcohol Effects on Mesolimbic Neurons and Microglia.

Biomedicines·2025
Same author

Longitudinal associations between physical performance and cognition in individuals with Parkinson's disease.

Clinical parkinsonism & related disorders·2025

相关实验视频

Updated: Jun 28, 2025

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.8K

伊弗梅克丁增加了条状胆固醇活性,以促进多巴胺终端功能.

Hillary A Wadsworth1, Alicia M P Warnecke2, Joshua C Barlow1

  • 1Department of Cellular Biology and Physiology, and Neuroscience Program, Brigham Young University, 4005 LSB, Provo, UT, 84602, USA.

Cell & bioscience
|April 17, 2024
PubMed
概括

伊弗梅克丁 (IVM) 通过增加多巴胺终端的兴奋性,主要是通过增强胆固醇活性来增强大脑中的多巴胺释放. 这一发现表明IVM的新机制.

关键词:
美国FSCVV我从来没有使用过mectin.这是帕金森氏症.纯原性P2X4受体的使用接收器 接收器 接收器

更多相关视频

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.8K
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

21.9K

相关实验视频

Last Updated: Jun 28, 2025

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

25.8K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.8K
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

21.9K

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 伊弗梅克丁 (IVM) 是一种抗寄生虫药物,已知会影响无脊椎动物的离子通道.
  • IVM还调节脊椎动物的离子通道,并显示出对帕金森病治疗的临床前前景,可能通过增强L-DOPA治疗.
  • 通过IVM影响多巴胺终端功能的精确机制尚未完全理解.

研究的目的:

  • 为了研究伊弗梅克对多巴胺终端功能的药理作用.
  • 确定纯能P2X4和尼古丁性乙胆受体在调解IVM对多巴胺释放的影响中的作用.
  • 为了阐明IVM如何影响L-DOPA治疗的背景下多巴胺释放.

主要方法:

  • 电化学检测被用来测量在背上条纹体中释放的多巴胺.
  • 实验涉及非激活P2X4受体和对抗尼古丁受体,以评估它们在IVM影响中的作用.
  • 监测了胆固醇内部神经元的发射,以评估IVM对神经元活动的影响.
  • 进行了L-DOPA和IVM的同时应用,以评估对多巴胺释放的联合作用.

主要成果:

  • 伊弗梅克显著增强了脊椎条纹体中多巴胺的释放.
  • 静脉注射对多巴胺释放的影响并不依赖P2X4受体,而是被尼古丁受体对抗阻断.
  • IVM增强了条状胆性内部神经元的发射.
  • 联合L-DOPA和IVM治疗增加了多巴胺的释放,转变表明终端刺激性增强而不是囊泡含量增加.

结论:

  • 伊弗梅克主要通过增强影响多巴胺终端的胆固醇活性来增加条状多巴胺释放.
  • 该机制涉及终端刺激性增加,而不是膀性多巴胺含量变化.
  • 这些发现突出了IVM在调节多巴胺基神经传递中的新作用,这对帕金森病研究有意义.